Orchard Therapeutics
Orchard is a biopharmaceutical company that develops and commercializes gene therapies for the treatment of inherited diseases.
Business Model:
Revenue: $16.9M
Employees: 201-500
Industries / Tags:
Detailed Orchard Therapeutics Information
Geographic Data
Address: 108 Cannon Street
City: London
State: england
Zip: EC4N 6EU
Country: GB
Financial Info
Stage:
post ipo equity
Raised Last:
$150M
Raised Total:$461M
Social
Metrics
3,074,851Website Global Rank
5,529Website Monthly Traffic
Twitter Followers
Description
Orchard is a biopharmaceutical company that develops and commercializes gene therapies for the treatment of inherited diseases.
Contact Phone:
+12038088286
Contact Email:
Orchard Therapeutics went public on 10/31/2018 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
10/31/2018
IPO Valuation:
$1B
Ticker Symbol:
ORTX
IPO Price:
$14/share
Amount Raised:
$225M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
